Skip to content

Clinical trials

Phase 1 Burkitt Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Phase 1 Country / region: China Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20173
20185
20197
20204
20212
20223
20232
20246
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status23
Recruiting13
Not yet recruiting9
Terminated2
Withdrawn2
Active, not recruiting1
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China4
Hebei Yanda Ludaopei Hospital3
The First Affiliated Hospital of Soochow University3
Zhejiang University3
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China2
Anhui Provincial Hospital2
The General Hospital of Western Theater Command2
Yan'an Affiliated Hospital of Kunming Medical University2
Beijing GoBroad Hospital1
Beijing Immunochina Medical Science & Technology Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma51
Lymphoma, B-Cell16
Recurrence5
Multiple Myeloma4
Leukemia, Myeloid, Acute3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Leukemia2
Lymphoma2
Lymphoma, Follicular2
Anemia, Hemolytic, Autoimmune1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.